EDITAS MEDICINE INC (EDIT) Stock Income Statement
NASDAQ:EDIT - Nasdaq - US28106W1036 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 32.31M | 78.12M | 19.71M | 25.54M | 90.73M | |||
| Operating Expenses | 271.23M | 247.30M | 245.66M | 218.69M | 225.57M | |||
| Research and Development | 199.25M | 177.65M | 174.96M | 142.51M | 158.00M | |||
| Selling, General, and Administrative Expenses | 71.99M | 69.65M | 70.70M | 76.18M | 67.58M | |||
| Operating Income | -238.92M | -169.18M | -225.95M | -193.15M | -134.84M | |||
| Interest Income/Expense | 14.06M | 17.57M | 4.23M | 2.34M | 2.61M | |||
| Other Income/Expense | -3.00K | -1.60M | 1.29M | -1.70M | 16.26M | |||
| Non Recurring Items | -12.23M | N/A | N/A | N/A | N/A | |||
| Income Before Taxes | -237.09M | -153.22M | -220.43M | -192.50M | -115.98M | |||
| Income Tax | 0.00 | N/A | N/A | N/A | N/A | |||
| Net Income | -237.09M | -153.22M | -220.43M | -192.50M | -115.98M | |||
| EBITDA | -233.11M | -163.12M | -219.61M | -188.10M | -130.88M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -2.88 | -2.02 | -3.21 | -2.85 | -1.98 | |||
| Non GAAP EPS | -2.88 | -2.05 | -3.21 | -2.85 | -2.00 | |||
| Statistics | ||||||||
| Profit Margin | -733.72% | -196.13% | -1118.37% | -753.72% | -127.83% | |||
| Operating Profit Margin | -739.37% | -216.56% | -1146.37% | -756.26% | -148.62% | |||
All data in USD